GO:0035434 copper ion transmembrane transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035434 (copper ion transmembrane transport) describes the directed movement of copper cations across a membrane, a process essential for copper homeostasis and cuproenzyme biogenesis.
• High-affinity copper transporter 1 (CTR1/SLC31A1) mediates saturable, energy-independent copper uptake and is the primary entry route for copper in mammalian cells.
• Copper-transporting P1B-type ATPases (ATP7A and ATP7B) use ATP hydrolysis to pump copper across membranes and are structurally conserved from bacteria to humans.
• Dysregulated copper transport is linked to inflammatory bowel disease, diabetes mellitus, acute pancreatitis, and copper toxicity in intestinal epithelial cells.
• Glutaredoxin 1 (GLRX1) promotes copper toxicity in intestinal epithelial cells, revealing redox regulation of copper transport in inflammation.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of copper transport genes in disease and physiology.
Description
Copper is an essential trace element that serves as a catalytic cofactor for enzymes involved in respiration, iron metabolism, antioxidant defense, and neurotransmitter synthesis. Because free copper is redox-active and potentially toxic, cells have evolved dedicated transport systems to move copper ions across membranes in a controlled manner. The Gene Ontology term GO:0035434, copper ion transmembrane transport, captures this directed movement of copper cations across a membrane, a process that is fundamental to copper homeostasis and cuproenzyme function. The transport of copper across membranes is mediated by a suite of evolutionarily conserved proteins, including the high-affinity copper transporter CTR1 (SLC31A1) and the copper-transporting P1B-type ATPases ATP7A and ATP7B. CTR1 mediates the majority of copper uptake into cells, while ATP7A and ATP7B pump copper into the secretory pathway and out of cells, respectively. The structural and mechanistic basis of copper transport has been illuminated by recent structural studies of P1B-type ATPases, which reveal how ion uptake is coupled to ATP hydrolysis. In this article, we provide a research-grade overview of GO:0035434, covering its definition, molecular mechanism, key genes, regulation, disease relevance, and experimental methods for studying copper ion transmembrane transport.
copper ion transmembrane transport At A Glance
| GO ID | GO:0035434 |
|---|---|
| GO term | copper ion transmembrane transport |
| Ontology | biological_process |
| Synonym | copper cation transmembrane transport; copper ion membrane transport |
| Major function | Directed movement of copper cations across a membrane, enabling copper uptake, efflux, and intracellular distribution |
| Key transporters | CTR1 (SLC31A1), ATP7A, ATP7B, and other P1B-type ATPases |
| Cellular locations | Plasma membrane, endosomal membrane, trans-Golgi network, and mitochondrial inner membrane |
| Energy coupling | ATP hydrolysis for P1B-type ATPases; energy-independent facilitated diffusion for CTR1 |
| Related diseases | Inflammatory bowel disease, diabetes mellitus, acute pancreatitis, and copper toxicity |
What Is GO:0035434?
GO:0035434 (copper ion transmembrane transport) is defined as the directed movement of copper cation across a membrane. This biological process encompasses the translocation of copper ions (Cu+ or Cu2+) from one side of a lipid bilayer to the other, often against a concentration gradient, and is mediated by specific membrane proteins such as channels, carriers, and pumps. The term includes both the high-affinity uptake of copper into cells and the efflux or sequestration of copper into intracellular compartments, processes that are essential for maintaining copper homeostasis and preventing copper toxicity.
Why Is copper ion transmembrane transport Important in Cell Biology?
Copper ion transmembrane transport is critical for maintaining intracellular copper homeostasis, supplying copper to cuproenzymes such as cytochrome c oxidase and superoxide dismutase, and preventing the accumulation of toxic free copper. Defects in copper transport proteins cause severe human disorders, including Menkes disease and Wilson disease, and contribute to the pathogenesis of inflammatory bowel disease, diabetes, and acute pancreatitis. Understanding the molecular mechanisms of copper transport is therefore essential for developing targeted therapies and for interpreting the role of copper in health and disease.
• Maintains copper homeostasis by balancing uptake, efflux, and intracellular sequestration.
• Supplies copper to cuproenzymes involved in mitochondrial respiration, antioxidant defense, and neurotransmitter synthesis.
• Prevents copper-induced oxidative stress and toxicity in tissues such as the intestinal epithelium.
• Dysregulation is linked to inflammatory bowel disease through glutaredoxin 1-mediated copper toxicity.
• Altered copper transport contributes to diabetes mellitus and its complications.
• Copper transport crosstalk with calcium and iron signals is implicated in acute pancreatitis.
• CTR1 also transports cisplatin, linking copper transport to cancer chemotherapy response.
• P1B-type ATPase structures provide templates for drug design targeting copper transport.
• Copper transport is essential for immune cell function and host defense.
• CRISPR-based models enable causal testing of copper transport genes in disease models.
What Happens During copper ion transmembrane transport?
Copper uptake across the plasma membrane
In simple terms: Copper enters the cell through a dedicated transporter called CTR1.
The first step in copper ion transmembrane transport is the high-affinity uptake of copper across the plasma membrane, primarily mediated by copper transporter 1 (CTR1/SLC31A1). CTR1 is a homotrimeric membrane protein that facilitates the saturable, energy-independent transport of copper ions and also mediates the uptake of cisplatin. Kinetic studies have shown that CTR1 transport is rate-limiting for copper accumulation and is regulated by extracellular copper levels.
Intracellular copper trafficking and sequestration
In simple terms: Once inside, copper is handed off to chaperones and delivered to target compartments.
After uptake, copper is bound by cytosolic copper chaperones and delivered to the secretory pathway, mitochondria, and other organelles. This intracellular trafficking ensures that copper reaches cuproenzymes without generating toxic free radicals. The directed movement of copper across endosomal and Golgi membranes is a key component of GO:0035434 and is mediated by transporters such as ATP7A and ATP7B.
ATP-driven copper efflux and vesicular transport
In simple terms: Pumps use ATP to push copper out of cells or into vesicles.
Copper-transporting P1B-type ATPases, including ATP7A and ATP7B, use the energy of ATP hydrolysis to pump copper across membranes against a concentration gradient. Structural studies of P1B-type ATPases have revealed the ion uptake pathway and the conformational changes that couple ATP binding and hydrolysis to copper translocation. These pumps are essential for copper efflux from cells and for loading copper into the secretory pathway for incorporation into cuproenzymes.
Redox regulation of copper transport
In simple terms: The redox state of the cell can change how copper moves.
Copper transport is influenced by the cellular redox environment. Glutaredoxin 1 (GLRX1) has been shown to promote intestinal epithelial cell copper toxicity in inflammatory bowel disease, indicating that redox regulators can modulate copper transport and toxicity. Additionally, cuprous ions can induce Cl-/OH- exchange across erythrocyte membranes, demonstrating that copper can affect ion transport processes beyond dedicated copper transporters.
Copper transport in specialized cells and crosstalk
In simple terms: Copper transport interacts with calcium and iron signals in tissues like the pancreas.
In acinar cells of the pancreas, copper signals crosstalk with calcium and iron transport pathways, contributing to the pathophysiology of acute pancreatitis. This crosstalk highlights that copper ion transmembrane transport is not an isolated process but is integrated with other ion transport systems. Such integration is important for understanding how copper imbalance can trigger or exacerbate disease.
Key Genes Involved in GO:0035434 copper ion transmembrane transport
The following genes encode proteins that directly mediate or regulate copper ion transmembrane transport (GO:0035434) and are commonly studied in copper biology.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC31A1 (CTR1) | High-affinity copper uptake across the plasma membrane | Knockout reduces copper uptake; target for cancer chemotherapy studies |
| ATP7A | ATP-driven copper efflux and delivery to secretory pathway | Mutations cause Menkes disease; structural studies of P1B-type ATPases |
| ATP7B | ATP-driven copper efflux, biliary excretion | Mutations cause Wilson disease; model for copper overload |
| GLRX1 | Redox regulation of copper toxicity in intestinal epithelium | Knockout protects against copper toxicity in IBD models |
| SLC31A2 (CTR2) | Copper transport in endosomes and lysosomes | Less studied; potential modifier of copper homeostasis |
| ATOX1 | Cytosolic copper chaperone delivering copper to ATP7A/B | Knockout impairs copper efflux and cuproenzyme maturation |
| CCS | Copper chaperone for SOD1 | Knockout affects antioxidant defense and copper distribution |
| COX17 | Mitochondrial copper chaperone for cytochrome c oxidase | Knockout impairs respiration and copper delivery to mitochondria |
| MT1A | Metallothionein, copper sequestration | Overexpression buffers free copper and protects against toxicity |
| MT2A | Metallothionein, copper sequestration | Modulates copper availability and toxicity |
| SLC11A1 (NRAMP1) | Divalent metal transporter with copper transport activity | Contributes to macrophage copper handling |
| SLC11A2 (DMT1) | Divalent metal transporter, may transport copper | Studied in iron-copper crosstalk |
| COMMD1 | Regulates ATP7B stability and copper excretion | Knockout causes copper accumulation in liver |
| XIAP | Regulates copper homeostasis via COMMD1 | Links apoptosis and copper transport |
| ATP7A (isoform) | Copper transport in polarized epithelia | Tissue-specific knockout models |
| ATP7B (isoform) | Copper transport in hepatocytes | Liver-specific knockout models |
| SCO1 | Mitochondrial copper delivery to cytochrome c oxidase | Knockout causes copper deficiency in mitochondria |
How Is copper ion transmembrane transport Regulated?
Copper ion transmembrane transport is regulated at multiple levels. CTR1-mediated copper uptake is downregulated by high extracellular copper, which triggers CTR1 endocytosis and degradation. ATP7A and ATP7B are regulated by copper-dependent trafficking between the trans-Golgi network and the plasma membrane or vesicles. Redox regulators such as glutaredoxin 1 can modulate copper toxicity in intestinal epithelial cells, linking copper transport to oxidative stress responses. Additionally, copper transport crosstalk with calcium and iron signaling pathways in pancreatic acinar cells suggests integration with broader ion homeostasis networks.
copper ion transmembrane transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GLRX1 | Inflammatory bowel disease, copper toxicity | Intestinal epithelial cell knockout and overexpression |
| SLC31A1 (CTR1) | Cisplatin response, copper uptake | Knockout and point-mutation cell lines |
| ATP7A | Menkes disease, copper efflux | Knock-in of patient mutations in cell models |
| ATP7B | Wilson disease, copper overload | Liver-specific knockout or knock-in models |
| SLC11A1 | Macrophage copper handling, infection | Knockout macrophages and infection models |
Copper transport in inflammatory bowel disease
Glutaredoxin 1 (GLRX1) promotes intestinal epithelial cell copper toxicity in inflammatory bowel disease, indicating that dysregulated copper transport and redox imbalance contribute to mucosal damage. Targeting GLRX1 or copper transport pathways may offer therapeutic strategies for IBD.
Copper transport in diabetes mellitus
Copper homeostasis is altered in diabetes mellitus, and disturbances in copper transport can affect insulin secretion and oxidative stress. Studies dissecting copper homeostasis in diabetes highlight the need to understand how copper transporters contribute to disease progression.
Copper transport in acute pancreatitis
In acinar cells, copper signals crosstalk with calcium and iron transport pathways, and this crosstalk is implicated in the pathogenesis of acute pancreatitis. Copper transport may therefore be a modifier of pancreatic injury.
Copper transport and cancer chemotherapy
CTR1 mediates the uptake of cisplatin, a widely used chemotherapeutic agent, linking copper transport to drug response and resistance. Understanding CTR1-mediated transport mechanisms can inform strategies to modulate cisplatin sensitivity.
From copper ion transmembrane transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CTR1 reduce copper uptake and cisplatin sensitivity? | SLC31A1 knockout cell line |
| How do ATP7B mutations affect copper efflux? | ATP7B point-mutation knock-in hepatocyte model |
| Does GLRX1 mediate copper toxicity in intestinal epithelium? | GLRX1 knockout and overexpression in epithelial cells |
| What is the role of ATP7A in copper delivery to cuproenzymes? | ATP7A knockout or tagged knock-in in fibroblasts |
| Does copper transport crosstalk with calcium signaling in pancreatitis? | Acinar cell-specific knockout of copper transporters |
| Can overexpression of metallothionein protect against copper toxicity? | MT1A or MT2A overexpression cell lines |
How to Study the copper ion transmembrane transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| 64Cu uptake assay | Rate of copper influx | Comparing wild-type and knockout cells |
| ATP hydrolysis assay | P1B-type ATPase activity | Testing ATP7A/B mutants |
| X-ray crystallography / cryo-EM | Structure of copper transporters | Understanding ion uptake mechanism |
| RNA-seq | Expression of copper transport genes | Profiling copper-responsive transcriptome |
| Proteomics | Protein levels of transporters and chaperones | Identifying copper-regulated proteins |
| Fluorescent copper sensors | Intracellular copper dynamics | Live-cell imaging of copper transport |
| CRISPR knockout screening | Genes required for copper transport | Identifying novel copper homeostasis regulators |
| Site-directed mutagenesis | Functional residues in transporters | Mapping copper-binding sites |
Measuring copper transport activity
Copper transport activity can be measured using radioactive copper (64Cu) uptake assays, which quantify the rate of copper accumulation in cells over time. These assays are used to compare wild-type and knockout cells to determine the contribution of specific transporters.
Structural and biochemical approaches
Structural studies of P1B-type ATPases using X-ray crystallography and cryo-electron microscopy have revealed the ion uptake pathway and conformational changes during copper transport. Biochemical assays measuring ATP hydrolysis can quantify pump activity.
Gene expression and proteomics
RNA-seq and quantitative proteomics can assess the expression of copper transporters and chaperones under different copper conditions. These methods help identify regulatory networks controlling copper ion transmembrane transport.
Imaging copper dynamics
Fluorescent copper sensors and live-cell imaging enable real-time visualization of copper transport and distribution in cells. These tools are valuable for studying dynamic changes in copper homeostasis.
How CRISPR Can Be Used to Study GO:0035434 copper ion transmembrane transport
Knockout
CRISPR knockout of copper transport genes such as SLC31A1, ATP7A, or ATP7B enables loss-of-function studies to determine their role in copper uptake, efflux, and cellular copper homeostasis. Knockout cell lines are valuable for measuring copper transport rates and sensitivity to copper toxicity.
Point Mutation
Point mutations in copper transporter genes, such as those found in Wilson disease (ATP7B) or Menkes disease (ATP7A), can be introduced using CRISPR base editing or homology-directed repair to model disease-associated variants. These models help dissect the functional impact of specific residues on copper transport.
Knock-in
Knock-in of tagged copper transporters (e.g., GFP-ATP7B) allows visualization and biochemical isolation of transport complexes. Knock-in of patient mutations provides isogenic models for studying copper transport defects.
Overexpression
CRISPR activation or cDNA overexpression of copper transporters and chaperones (e.g., MT1A, GLRX1) can test gain-of-function effects on copper homeostasis and toxicity. Overexpression models are useful for identifying protective or sensitizing factors in copper-related diseases.
How EDITGENE Supports copper ion transmembrane transport Research
Researchers studying copper ion transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in copper uptake, efflux, or toxicity. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for copper ion transmembrane transport research.
Frequently Asked Questions About copper ion transmembrane transport
What is GO:0035434 copper ion transmembrane transport?
GO:0035434 is a Gene Ontology biological process term defined as the directed movement of copper cation across a membrane.
What genes are involved in copper ion transmembrane transport?
Key genes include SLC31A1 (CTR1), ATP7A, ATP7B, GLRX1, ATOX1, and metallothioneins such as MT1A.
How does CTR1 mediate copper uptake?
CTR1 is a high-affinity copper transporter that facilitates saturable, energy-independent copper influx and also transports cisplatin.
What is the role of ATP7A and ATP7B in copper transport?
ATP7A and ATP7B are P1B-type ATPases that use ATP hydrolysis to pump copper across membranes for efflux and cuproenzyme loading.
How is copper ion transmembrane transport regulated?
It is regulated by copper-dependent trafficking of transporters, endocytosis of CTR1, and redox regulators such as glutaredoxin 1.
What diseases are linked to defective copper transport?
Defective copper transport is linked to Menkes disease, Wilson disease, inflammatory bowel disease, diabetes mellitus, and acute pancreatitis.
How can I study copper ion transmembrane transport in the lab?
Common methods include 64Cu uptake assays, ATP hydrolysis assays, structural biology, RNA-seq, proteomics, and CRISPR knockout models.
What CRISPR models are available for copper transport genes?
Knockout, point mutation, knock-in, and overexpression models can be generated for genes such as SLC31A1, ATP7A, ATP7B, and GLRX1.
Does copper transport interact with other ion transport pathways?
Yes, copper signals crosstalk with calcium and iron transport in pancreatic acinar cells, and cuprous ions can induce Cl-/OH- exchange in erythrocytes.
Why is copper transport important in cancer?
CTR1 mediates cisplatin uptake, so copper transport status can influence chemotherapy response and resistance.
Conclusion
Copper ion transmembrane transport (GO:0035434) is a fundamental biological process that controls copper uptake, distribution, and efflux across cellular membranes. The coordinated action of CTR1, ATP7A, ATP7B, and associated chaperones ensures that copper is delivered to cuproenzymes while preventing toxicity. Dysregulation of this process contributes to inflammatory bowel disease, diabetes, acute pancreatitis, and cancer chemotherapy response. Continued research using CRISPR-engineered models and advanced structural and functional methods will further illuminate the mechanisms and therapeutic potential of targeting copper transport.
References
- 1. Bogdanova AY et al.. 1999. Copper effects on ion transport across lamprey erythrocyte membrane: Cl(-)/OH(-) exchange induced by cuprous ions.. Toxicol Appl Pharmacol 159(3):204-13 PMID: 10486307
- 2. Harris ED. 1993. The transport of copper.. Prog Clin Biol Res 380:163-79 PMID: 8456124
- 3. Salustros N et al.. 2022. Structural basis of ion uptake in copper-transporting P(1B)-type ATPases.. Nat Commun 13(1):5121 PMID: 36045128
- 4. Liang ZD et al.. 2009. Mechanistic comparison of human high-affinity copper transporter 1-mediated transport between copper ion and cisplatin.. Mol Pharmacol 76(4):843-53 PMID: 19570948
- 5. Zhang T et al.. 2026. Glutaredoxin 1 promotes intestinal epithelial cell copper toxicity in inflammatory bowel disease.. Redox Biol 93:104164 PMID: 41985411
- 6. Wang H et al.. 2024. Ion channels in acinar cells in acute pancreatitis: crosstalk of calcium, iron, and copper signals.. Front Immunol 15:1444272 PMID: 39606246
- 7. Maryon EB et al.. 2013. Rate and regulation of copper transport by human copper transporter 1 (hCTR1).. J Biol Chem 288(25):18035-46 PMID: 23658018
- 8. Lowe J et al.. 2017. Dissecting copper homeostasis in diabetes mellitus.. IUBMB Life 69(4):255-262 PMID: 28276155
